Table 2. PEPFAR-supported centralized VL and EID laboratories and instruments used for SARS-CoV-2 testing in 16 countries in their response to the COVID-19 pandemic, April 1, 2020–March 31, 2021*.
| Country | No. PEPFAR laboratories | No. (%) PEPFAR laboratories conducting SARS-CoV-2 testing | No. instruments | No. HIV VL and EID tests conducted in PEPFAR laboratories† | No. SARS-CoV-2 tests conducted in PEPFAR laboratories | No. SARS-CoV-2 tests conducted nationally (5) | % SARS-CoV-2 tests performed at PEPFAR laboratories‡ |
|---|---|---|---|---|---|---|---|
| Angola | 2 | 2 (100) | 2 | NA | No data | NA | NA |
| Cameroon | 13 | 10 (77) | 7 | NA | No data | NA | NA |
| DR | 4 | 1 (25) | 1 | 26,930 | 588,736 | 1,176,196§ | 50 |
| DRC | 6 | 5 (83) | 2 | 176,249 | 5,565 | No data | NA |
| Eswatini | 4 | 1 (25) | 1 | NA | No data | NA | NA |
| Ethiopia | 20 | 15 (75) | 15 | 325,276 | 630,119 | 2,355,880¶ | 27 |
| Kenya | 10 | 8 (80) | 25 | 1,348,294 | 401,402 | 571,413# | 70 |
| Lesotho | 6 | 3 (50) | 0 | 189,631 | 47,006 | No data | NA |
| Malawi | 11 | 11 (100) | 18 | 580,578 | 113,738 | 56,987¶ | 200 |
| Mozambique | 16 | 5 (31) | 5 | 1,061,555 | 378,029 | 472,224# | 80 |
| Namibia | 8 | 4 (50) | 3 | NA | No data | NA | NA |
| Nigeria | 12 | 4 (33) | 10 | 1,987,452 | 208,317 | 702,055§ | 30 |
| South Sudan | 1 | 0 (0) | 0 | NA | 0 | NA | NA |
| Uganda | 1 | 1 (100) | 11 | 1,459,010 | 279,176 | 851,514§ | 33 |
| Zambia | 24 | 24 (100) | 10 | 1,025,000 | 600,000 | 1,218,207¶ | 49 |
| Zimbabwe | 15 | 15 (100) | 11 | 650,423 | 89,504 | 428,121# | 21 |
| Total | 153 | 109 (71) | 121 | 8,830,398 | 3,341,592 | 7,832,597 | 42 |
*DR, Dominican Republic; DRC, Democratic Republic of Congo; EID, early infant diagnosis; NA, not applicable; PEPFAR, US President’s Emergency Plan for AIDS Relief; VL, viral load. †Number of HIV VL and EID and national SARS-CoV-2 tests are only shown for those countries reporting SARS-CoV-2 testing volumes in PEPFAR-supported laboratories. For countries not reporting SARS-CoV-2 testing volumes in PEPFAR-supported laboratories, HIV VL and EID and national SARS-CoV-2 test numbers are listed as NA. ‡ Percentage of SARS-CoV-2 tests performed at PEPFAR-supported laboratories was only calculated for countries with data available for both PEPFAR and national SARS-CoV-2 testing numbers. For countries without both PEPFAR and national SARS-CoV-2 testing numbers available, % of SARS-CoV-2 tests performed at PEPFAR laboratories is listed as NA. §National SARS-CoV-2 test numbers represent the number of PCR tests. ¶Test type for national SARS-CoV-2 test numbers was uncited or listed as unclear. #National SARS-CoV-2 test numbers represent the number of PCR and antigen tests.